SecBot SecBot
SECBOTREPLAY Home › Report › PCVX

PCVX · Two top C-suite executives at Vaxcyte (CEO and CFO) sold a combined…

Vaxcyte, Inc. · CLUSTER filed Jun 18, 2026 at 20:08 ET

At the news

NEUTRALIMPACT 3/10

CLUSTER filed Jun 18, 2026 at 20:08 ET

Two top C-suite executives at Vaxcyte (CEO and CFO) sold a combined ~$542K in open-market sales on June 18, 2026, following the exercise of stock options. The sales are small relative to the $7.3B market cap (~0.007%), making them routine and likely tax-related or liquidity-driven. No material bearish signal.

  • CEO Grant Pickering sold 225 shares for ~$11.8K on June 18
  • CFO Andrew Guggenhime sold 10,000 shares for $530K on June 18
  • Both sales followed option exercises at nominal prices ($0 and $1.79/$5.35)
  • Total open-market sales: ~$542K, or 0.007% of $7.3B market cap

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access